Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain

Journal of Comparative Neurology

Volumn 417, Issue 2, 2000, Pages 181-194

  Riad, Mustapha ^a   Garcia, Sylvia ^a   Watkins, Kenneth C ^a   Jodoin, Nicolas ^a   Doucet, Édith ^b   Langlois, Xavier ^b   El Mestikawy, Salah ^b   Hamon, Michel ^b   Descarries, Laurent ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cellular and subcellular distribution; Central nervous system; Immunocytochemistry; Serotonin receptors

Indexed keywords

PEROXIDASE; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; DENDRITE; DORSAL RAPHE NUCLEUS; GLOBUS PALLIDUS; GRANULE CELL; HIPPOCAMPUS; IMMUNOGOLD STAINING; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; NEUROMODULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY; SEROTONIN RELEASE; SUBSTANTIA NIGRA;

ANIMALS; AXONS; BRAIN; DENDRITES; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; NERVE ENDINGS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SUBCELLULAR FRACTIONS;

EID: 0034615164     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A     Document Type: Article

References (98)

1. Andrade R, Nicoll RA. 1987a. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J Physiol (Lond) 394:99-124.
2. Andrade R, Nicoll RA. 1987b. Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 336:5-10.
3. Aoki C, Venkatesan C, Go CG, Forman R, Kurose H. 1998. Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cereb Cortex 8:269-277.
4. Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ, Loh HH, Law PY, Wessendorf MW, Elde R. 1995. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15:3328-3341.
5. Azmitia EC, Yu I, Akbari HM, Kheck N, Whitaker-Azmitia PM, Marshak DR. 1992. Antipeptide antibodies against the 5-HT1A receptor. J Chem Neuroanat 5:289-298.
6. Baude A, Nusser Z, Molnar E, McIlhinney RAJ, Somogyi P. 1995. High-resolution immunogold localization of AMPA-type glutamate receptor subunits at synaptic and nonsynaptic sites in rat hippocampus. Neuroscience 69:1031-1055.
7. Baumgarten HG, Göthert M, editors. 1997. Serotoninergic neurons and 5-HT receptors in the CNS. Berlin: Springer.
8. Bernard V, Somogyi P, Bolam JP. 1997. Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J Neurosci 17:819-833.
9. Bertin B, Freissmuth M, Breyer RM, Schutz W, Strosberg AD, Marullo S. 1992. Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. J Biol Chem 267:8200-8206.
10. Blier P, de Montigny C. 1987. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1:470-480.
11. Bohmaker K, Eison AS, Yocca FD, Meller E. 1993. Comparative effects of chronic 8-OH-DPAT, gepirone and ipsapirone treatment on the sensitivity of somatodendritic 5-HT1A autoreceptors. Neuropharmacology 32:527-534.
12. Bolaños-Jimenez F, Manhaes de Castro R, Fillion G. 1994. Effect of chronic antidepressant treatment on 5-HT1B presynaptic heteroreceptors inhibiting acetylcholine release. Neuropharmacology 33:77-81.
13. Boschert U, Aït Amara D, Segu L, Hen R. 1994. The mouse 5-hydroxytryptamine 1B receptor is localized predominantly on axon terminals. Neuroscience 58:167-182.
14. Bruinvels AT, Palacios JM, Hoyer D. 1993. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn Schmiedebergs Arch Pharmacol 347:569-582.
15. Bruinvels AT, Landwehrmeyer B, Gustafson EL, Durkin MM, Mengod G, Branchek TA, Hoyer D, Palacios JM. 1994. Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33:367-386.
16. Bunin MA, Wightman RM. 1998. Quantitative evaluation of 5-hydroxytryptamine (5-HT) neuronal release and uptake: an investigation of extrasynaptic transmission. J Neurosci 18:4854-4860.
17. Caillé I, Dumartin B, Bloch B. 1996. Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation. Brain Res 730:17-31.
18. Chalmers DT, Watson SJ. 1991. Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain - a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res 561:51-60.
19. Chaput Y, de Montigny C. 1988. Effects of the 5-hydroxytryptamine 1 receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: Electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther 246:359-370.
20. Darmon M, Langlois X, Suffisseau L, Fattaccini CM, Hamon M. 1998. Differential membrane targeting and pharmacological characterization of chimeras of rat serotonin 5-HT1A and 5-HT1B receptors expressed in epithelial LLC-PK1 cells. J Neurochem 71:2294-2303.
21. de Montigny C, Blier P, Chaput Y. 1984. Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment. Neuropharmacology 23:1511-1520.
22. Descarries L, Audet MA, Doucet G, Garcia S, Oleskevich S, Séguéla P, Soghomonian J-J, Watkins KC. 1990. Morphology of central serotonin neurons. Ann N Y Acad Sci 60:81-91.
23. Descarries L, Watkins KC, Garcia S, Bosler O, Doucet G. 1996. Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immucytochemical analysis. J Comp Neurol 375:167-186.
24. Descarries L, Gisiger V, Steriade M. 1997. Diffuse transmission by acetyl-choline in the CNS. Prog Neurobiol 53:603-625.
25. Dong J, de Montigny C, Blier P. 1997. Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe. Naunyn Schmiedebergs Arch Pharmacol 356:303-311.
26. Dong J, de Montigny C, Blier P. 1998. Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors: electrophysiological studies in the rat hippocampus and dorsal raphe. J Pharmacol Exp Ther 286:1239-1247.
27. Doucet E, Pohl M, Fattaccini CM, Adrien J, El Mestikawy S, Hamon M. 1995. In situ hybridization evidence for the synthesis of 5-HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain. Synapse 19:8-28.
28. Elhusseiny A, Hamel E. 1999. 5-HT1 receptors in human and bovine intracortical microarterioles mediate both a constriction and a nitric oxide (NO)-dependent dilation. J Cereb Blood Flow Metab 19:(Suppl 1)S-235.
29. El Mestikawy S, Riad M, Laporte AM, Vergé D, Daval G, Gozlan H, Hamon M. 1990. Production of specific anti-5-HT1A receptor antibodies in rabbits injected with a synthetic peptide. Neurosci Lett 118:189-192.
30. Engel G, Gothert M, Hoyer D, Schlicker E, Hillenbrand K. 1986. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn Schmiedebergs Arch Pharmacol 332:1-7.
31. Fletcher A, Cliffe IA, Dourish CT. 1993. Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol Sci 14:41-48.
32. Gérard C, Langlois X, Gingrich J, Doucet E, Vergé D, Kia HK, Raisman R, Gozlan H, El Mestikawy S, Hamon M. 1994. Production and characterization of polyclonal antibodies recognizing the intracytoplasmic third loop of the 5-hydroxytryptamine 1A receptor. Neuroscience 62: 721-739.
33. Godbout R, Chaput Y, Blier P, de Montigny C. 1991. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine. I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission. Neuropharmacology 30:679-690.
34. Hadrava V, Blier P, Dennis T, Ortemann C, de Montigny C. 1995. Characterization of 5-hydroxytryptamine 1A properties of flesinoxan: in vivo electrophysiology and hypothermia study. Neuropharmacology 34: 1311-1326.
35. Hamon M, Fattaccini CM, Adrien J, Gallissot MC, Martin P, Gozlan H. 1988. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine 1A agonists with potential anxiolytic properties. J Pharmacol Exp Ther 246:745-752.
36. Hamon M, Lanfumey L, El Mestikawy S, Boni C, Miquel M-C, Bolanos F, Schechter L, Gozlan H. 1990. The main features of central 5-HT1 receptors. Neuropsychopharmacology 3:349-360.
37. Helke CJ, Capuano S, Tran N, Zhuo H. 1997. Immunocytochemical studies of the 5-HT1A receptor in ventral medullary neurons that project to the intermediolateral cell column and contain serotonin or tyrosine hydroxylase immunoreactivity. J Comp Neurol 379:261-270.
38. Héry F, Faudon M, Ternaux JP. 1982. In vivo release of serotonin in two raphe nuclei (raphe dorsalis and magnus) of the cat. Brain Res Bull 2:123-129.
39. Hillion J, Catelon J, Riad M, Hamon M, De Vitry F. 1994. Neuronal localization of 5-HT1A receptor mRNA and protein in rat embryonic brain stem cultures. Dev Brain Res 79:195-202.
40. Hjorth S, Tao R. 1991. The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal serotonin release in vivo: comparison with RU 24969. Eur J Pharmacol 209:249-252.
41. Holgate CS, Jackson P, Cowen PN, Bird CC. 1983. Immunogold-silver staining: new method of immunostaining with enhanced sensitivity. J Histochem Cytochem 31:938-944.
42. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA. 1994. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (5-HT). Pharmacol Rev 46:157-203.
43. Iravani MM, Kruk ZL. 1997. Real-time measurement of stimulated 5-hydroxytryptamine release in rat substantia nigra pars reticulata brain slices. Synapse 25:93-102.
44. Johnson SW, Mercuri NB, North RA. 1992. 5-Hydroxytryptamine 1B receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci 12:2000-2006.
45. Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H, Hamon M. 1994. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharmacol Exp Ther 268: 1432-1443.
46. Kennett GA, Marcou M, Dourish CT, Curzon G. 1987. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol 138:53-60.
47. Kia HK, Brisorgueil MJ, Hamon M, Calas A, Vergé D. 1996a. Ultrastructural localization of 5-hydroxytryptamine 1A receptors in the rat brain. J Neurosci Res 46:697-708.
48. Kia HK, Miquel M-C, Brisorgueil MJ, Daval G, Riad M, El Mestikawy S, Hamon M, Vergé D 1996b. Immunocytochemical localization of 5-HT1A receptors in the rat central nervous system. J Comp Neurol 365:289-305.
49. Langlois X, Gérard C, Darmon M, Chauveau J, Hamon M, El Mestikawy S. 1995. Immunolabeling of central serotonin 5-HT1D beta receptors in the rat, mouse, and guinea pig with a specific anti-peptide antiserum. J Neurochem 65:2671-2681.
50. Langlois X, El Mestikawy S, Arpin M, Triller A, Hamon M, Darmon M. 1996. Differential addressing of 5-HT1A and 5-HT1B receptors in transfected LLC-PK1 epithelial cells: a model of receptor targeting in neurons. Neuroscience 74:297-302.
51. Luján R, Roberts JDB, Shigemoto R, Ohishi H, Somogyi P. 1997. Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1a, mGluR2 and mGluR5, relative to neurotransmitter release sites. J Chem Neuroanat 13:219-241.
52. Maley BE, Engle MG, Humphreys S, Vascik DA, Howes KA, Newton BW, Elde RP. 1990. Monoamine synaptic structure and localization in the central nervous system. J Electron Microsc Techn 15:20-33.
53. Marsden CA, Conti J, Strope E, Curzon G, Adams RN. 1979. Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanaesthetized rat using in vivo voltammetry. Brain Res 171:85-99.
54. Matthiessen L, Kia HK, Daval G, Riad M, Hamon M, Vergé D. 1993. Immunocytochemical localization of 5-HT1A receptors in the rat immature cerebellum. Neuroreport 4:763-766.
55. Maura G, Raiteri M. 1986. Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. Eur J Pharmacol 129:333-337.
56. Milner TA, Lee A, Aicher SA, Rosin DL. 1998. Hippocampal alpha2a-adrenergic receptors are located predominantly presynaptically but are also found postsynaptically and in selective astrocytes. J Comp Neurol 395:310-327.
57. Mokler DJ, Larivière D, Johnson DW, Thériault NL, Bronzino JD, Dixon M, Morgane PJ 1998. Serotonin neuronal release from dorsal hippocampus following electrical stimulation of the dorsal and median raphe nuclei in conscious rats. Hippocampus 8:262-273.
58. Moukhles H, Bosler O, Bolam JP, Vallée A, Umbriaco D, Geffard M, Doucet G. 1997. Quantitative morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra. Neuroscience 76:1159-1171.
59. Mulheron JG, Casanas SJ, Arthur JM, Garnovskaya MN, Gettys TW, Raymond JR. 1994. Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s). J Biol Chem 269:12954-12962.
60. Nedergaard S, Bolam JP, Greenfield SA. 1988. Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature 333:174-177.
61. Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. 1996. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16:436-447.
62. Nissbrandt H, Waters N, Hjorth S. 1992. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Naunyn Schmiedebergs Arch Pharmacol 346:12-19.
63. Nusser Z, Roberts JD, Baude A, Richards JG, Sieghart W, Somogyi P. 1995. Immunocytochemical localization of the alpha 1 and beta2/3 subunits of the GABAA receptor in relation to specific GABAergic synapses in the dentate gyrus. Eur J Neurosci 7:630-646.
64. Olivier B, van Wijngaarden I, Soudijn W, editors. 1997. Serotonin receptors and their ligands. Pharmacochemistry Library 27. Amsterdam: Elsevier.
65. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates (2nd ed.). Sydney: Academic Press Australia.
66. Pickard GE, Smith BN, Belenky M, Rea MA, Dudek FE, Sollars PJ. (1999). 5-HT1B receptor-mediated presynaptic inhibition of retinal input to the suprachiasmatic nucleus. J Neurosci 19:4034-4045.
67. 3H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice. Neuroreport 29:353-359.
68. Portas CM, Bjorvatn B, Fagerland S, Gronli J, Mundal V, Sorensen E, Ursin R. 1998. On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep/wake cycle in the freely moving rat. Neuroscience 83:807-814.
69. Raiteri M, Maura G, Bonanno G, Pittaluga A. 1986. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. J Pharmacol Exp Ther 237:644-648.
70. Raymond JR, Olsen CL, Gettys TW. 1993. Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein alpha-subunits and lack of coupling to Gs alpha. Biochemistry 32: 11064-11073.
71. Remy SM, Schreiber R, Dalmus M De Vry J. 1996. Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology 125:89-91.
72. Riad M, El Mestikawy S, Vergé D, Gozlan H, Hamon M. 1991. Visualization and quantification of central 5-HT1A receptors with specific antibodies. Neurochem Int 19:413-423.
73. Riad M, Garcia S, Hamon M, Descarries L. 1995. Somatodendritic localization of the serotonin 5-HT1A receptor in adult rat brain. Soc Neurosci Abstr 21:978.
74. Riad M, Jodoin N, Garcia S, Langlois X, Darmon M, Hamon M, Descarries L. 1996. Axonal localization of the serotonin 5-HT1B receptor in rat brain. Soc Neurosci Abstr 22:1329.
75. Riad M, Garcia S, El Mestikawy S, Hamon M, Descarries L. 1997. Endothelial localization of 5-HT1B serotonin receptors in rat brain microvesaels. Soc Neurosci Abstr 23:1214.
76. Riad M, Tong X-K, El Mestikawy S, Hamon M, Hamel E, Descarries L. 1998. Endothelial expression of the 5-hydroxytryptamine 1B antimigraine drug receptor in rat and human brain microvessels. Neuroscience 86:1031-1035.
77. Ridet JL, Tamir H, Privat A. 1994. Direct immunocytochemical localization of 5-hydroxytryptamine receptors in the adult rat spinal cord: a light and electron microscopic study using an antiidiotypic antiserum. J Neurosci Res 38:109-121.
78. Ropert N. 1988. Inhibitory action of serotonin in CA1 hippocampal neurons in vitro. Neuroscience 26:69-81.
79. Rueter LE, de Montigny C, Blier P. 1998. In vivo electrophysiological assessment of the agonistic properties of flibanserin at pre- and postsynaptic 5-HT1A receptors in the rat brain. Synapse 29:392-405.
80. Sari Y, Lefèvre K, Bancila M, Quignon M, Miquel M-C, Langlois X, Hamon M, Vergé D. 1997. Light and electron microscopic immunocytochemical visualization of 5-HT1B receptors in the rat brain. Brain Res 760: 281-286.
81. Sari Y, Miquel M-C, Brisorgueil MJ, Ruiz G, Doucet E, Hamon M, Vergé D. 1999. Cellular and subcellular localization of 5-hydroxytryptamine 1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 88:899-915.
82. Saxena PR. 1995. 5-HT receptors: subtypes, functional responses and therapeutic relevance. Pharmacol Ther 66:339-368.
83. Schreiber R, De Vry J. 1993. 5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action? Prog Neuropsychopharmacol Biol Psychiatry 17:87-104.
84. Sesack SR, Aoki C, Pickel VM. 1994. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88-106.
85. Sharp T, Bramwell SR, Grahame-Smith DG. 1989. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96:283-290.
86. Shi ZR, Itzkowitz SH, Kim YS. 1988. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem 36:317-322.
87. Smiley JF, Levey AI, Ciliax BJ, Goldman-Rakic PS. 1994. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci USA 91:5720-5724.
88. Soghomonian J-J, Beaudet A, Descarries L. 1988. Ultrastructural relationships of central serotonin neurons. In: Osborne NN, Hamon M, editors. Neuronal serotonin. Chichester: John Wiley & Sons, p 57-92.
89. Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M. 1990. Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 2:1144-1154.
90. Sprouse JS, Aghajanian GK. 1987. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1:3-9.
91. Sprouse JS, Aghajanian GK. 1988. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27:707-715.
92. Swanson TH, Drazba JA, Rivkees SA. 1995. Adenosine A1 receptors are located predominantly on axons in the rat hippocampal formation. J Comp Neurol 363:517-531.
93. Swanson TH, Krahl SE, Liu YZ, Drazba JA, Rivkees SA. 1998. Evidence for physiologically active axonal adenosine receptors in the rat corpus callosum. Brain Res 784:188-198.
94. Trent F, Tepper JM. 1991. Dorsal raphe stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo. Exp Brain Res 84:620-630.
95. Trillat AC, Malagié I, Scearce K, Pons D, Anmella MC, Jacquot C, Hen R, Gardier AM. 1997. Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozygous mice lacking 5-HT1B receptors: in vivo microdialysis studies. J Neurochem 69:2019-2025.
96. Whitaker-Azmitia PM, Clarke C, Azmitia EC. 1993. Localization of 5-HT1A receptors to astroglial cells in adult rats: implications for neuronal-glial interactions and psychoactive drug mechanism of action. Synapse 14:201-205.
97. Yung KK, Bolam JP, Smith AD, Hersch SM, Ciliax BL, Levey AI. 1995. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65:709-730.
98. Zhou FC, Tao-Cheng J-H, Segu L, Patel T, Wang Y. 1998. Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence. Brain Res 805:241-254.